Pulse Biosciences (PLSE) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.28
- EPS estimate
- −$0.29
- EPS surprise
- +3.00%
- Revenue surprise
- −18.62%
- Revenue
- $434,000.00
- Revenue estimate
- $533,333.00
- Reported
- Aug 6, 2026
Pulse Biosciences reported Q2 2026 results on August 6, 2026. It posted a loss of $0.28 per share, slightly narrower than the expected $0.29 loss, a 3.00% beat. Revenue was $434,000, 18.62% below the $533,333 estimate. The loss was wider than the $0.20 per share of Q2 2025, which has no revenue figure in the table.
Pulse lost money in all 20 quarters shown. Annual losses per share narrowed from $1.63 in 2022 to $0.75 in 2023 and $0.67 in 2024, then widened to $0.75 in 2025. The loss has grown in recent quarters, from $0.18 in Q4 2025 to $0.24 in Q1 2026 and $0.28 in Q2 2026, the widest since Q3 2022. Revenue is small and patchy in the data: no figures appear from Q3 2022 through Q2 2025, and the four quarters since range from $86,000 to $434,000. Pulse beat the EPS estimate in 15 of the 19 quarters with an estimate; Q1 2025 had none.
Third-quarter results came out between October 30 and November 15 in each of the past five years. That points to early or mid November 2026 for the Q3 report. It will show how results compare with Q3 2025.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.29 | −$0.28 | +3.00% | $434,000.00 | SEC |
| Q1 2026 | May 4, 2026 | −$0.27 | −$0.24 | +11.81% | $400,000.00 | SEC |
| Q4 2025 | Feb 19, 2026 | −$0.27 | −$0.18 | +30.98% | $264,000.00 | SEC |
| Q3 2025 | Nov 5, 2025 | −$0.31 | −$0.20 | +34.58% | $86,000.00 | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.26 | −$0.20 | +23.54% | $0.00 | SEC |
| Q1 2025 | May 8, 2025 | $0.00 | −$0.17 | +0.00% | $0.00 | SEC |
| Q4 2024 | Mar 28, 2025 | −$0.24 | −$0.17 | +31.08% | $0.00 | SEC |
| Q3 2024 | Oct 30, 2024 | −$0.24 | −$0.16 | +34.83% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.24 | −$0.20 | +16.67% | $0.00 | SEC |
| Q1 2024 | May 7, 2024 | −$0.24 | −$0.14 | +40.54% | $0.00 | SEC |
| Q4 2023 | Mar 28, 2024 | −$0.24 | −$0.15 | +35.96% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.24 | −$0.15 | +36.71% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.24 | −$0.22 | +8.33% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.22 | −$0.23 | −3.00% | $0.00 | SEC |
| Q4 2022 | Mar 30, 2023 | −$0.24 | −$0.22 | +7.96% | −$9,000.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.46 | −1.36% | $0.00 | SEC |
| Q2 2022 | Aug 10, 2022 | −$0.40 | −$0.37 | +5.62% | $265,000.00 | SEC |
| Q1 2022 | May 11, 2022 | −$0.52 | −$0.58 | −10.84% | $444,000.00 | SEC |
| Q4 2021 | Mar 31, 2022 | −$0.51 | −$0.52 | −1.96% | $844,000.00 | SEC |
| Q3 2021 | Nov 15, 2021 | −$0.53 | −$0.48 | +9.99% | $574,000.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Pulse Biosciences (PLSE) last report earnings?
Pulse Biosciences last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did PLSE beat earnings estimates?
Yes. Pulse Biosciences reported EPS of −$0.28 for Q2 2026 against a −$0.29 estimate — a 3.00% beat.
How much revenue did PLSE report last quarter?
Pulse Biosciences reported $434,000.00 in revenue for Q2 2026, against a consensus estimate of $533,333.00.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.